Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Inventory (2019 - 2025)

Outset Medical (OM) has disclosed Inventory for 7 consecutive years, with $52.2 million as the latest value for Q2 2025.

  • On a quarterly basis, Inventory fell 15.18% to $52.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was $52.2 million, a 15.18% decrease, with the full-year FY2024 number at $59.4 million, up 20.67% from a year prior.
  • Inventory was $52.2 million for Q2 2025 at Outset Medical, down from $59.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $61.6 million in Q2 2024 to a low of $34.3 million in Q3 2021.
  • A 5-year average of $50.5 million and a median of $52.2 million in 2025 define the central range for Inventory.
  • Peak YoY movement for Inventory: skyrocketed 113.15% in 2021, then decreased 15.18% in 2025.
  • Outset Medical's Inventory stood at $39.2 million in 2021, then surged by 31.37% to $51.5 million in 2022, then fell by 4.39% to $49.2 million in 2023, then increased by 20.67% to $59.4 million in 2024, then fell by 12.02% to $52.2 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Inventory are $52.2 million (Q2 2025), $59.4 million (Q4 2024), and $61.6 million (Q2 2024).